DataMeds AI closed at $1.18 on Nov 5, down 20.81%, 80.6% below its highest close since Feb 13. Volume of 425.9K shares was 0.18× its 20-day average (below normal).
Split-adjusted performance: -59.0% over one month.
In the quarter ended Jun 30, 2024, revenue was $18.70K, down 94.9% from a year earlier, with a net margin of -9807.5%.
Short interest was 476.3K shares at the Oct 15 settlement, down 9.3% from the prior report (31.4% of float, 1.0 days to cover).
DataMEDS AI Inc is a healthcare technology and pharmaceutical logistics company. The group simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient.
What is MEDS's market cap?
$5.33M, based on the Nov 5 close of $1.18.
What is MEDS's P/E ratio?
1.3× trailing-twelve-month earnings of $4.22M.
Does DataMeds AI pay a dividend?
No regular cash dividend has been paid in the last year.
How much of MEDS is sold short?
476.3K shares, 31.4% of float, as of Oct 15, 2026.
What sector is MEDS in?
Consumer Discretionary, in the Wholesale Trade industry.
About DataMeds AI
DataMEDS AI Inc is a healthcare technology and pharmaceutical logistics company. The group simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. Its solutions provide a single, integrated platform for pharmacies, wholesale distribution, and a fulfillment network focused on Independent Pharmacies and Specialty Lite medications.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology